The simple, mobile and fast solution

Surgical removal of abnormal parathyroid glands is the only curative treatment for primary hyperparathyroidism. Monitoring parathyroid hormone (PTH) levels during surgery provides assurance that all overactive parathyroid tissue has been adequately excised, the surgical procedure can be concluded, and the patient returned to the ward.

The drop in iPTH levels after removal of the diseased gland is clearly visible, and can be used as an aid to provide a surgeon with the immediate feedback that the operation has been successful. The Stat-IO-iPTH system of Future Diagnostics is an aid in the monitoring of the PTH levels during Parathyroidectomies.

PTH_Steps_Assay
  • Results in 8 minutes
  • Provides immediate indication of surgical outcome
  • Time reduction of patient anesthesia
  • CE marked and CSA/UL/ETL listed instruments
  • Cleared by U.S. FDA
  • Decreased operating room time

In practice

Alexander Shifrin, MD | Jersey Shore University Medical Center
Visit webpage

UCLA | Endocrine Surgery
Visit webpage

ACC guideline

When a central laboratory is used, results should be available as soon as possible, preferably within 60 minutes. Point-of-care systems, if implemented at the bedside, have the advantage of reducing delays due to transportation and processing in a central laboratory and can eliminate delays due to the lack of availability of central laboratory assays at all hours.
J Am Coll Cardiol,2011; 57:215-367,doi:10.1016/ j.jacc. 2011.02.011